Solid Drug Diversion Prevention Starts With Data
People who work in the manufacturing industry may have more experience with supply chain management, but healthcare systems’ supply chains are a matter of life and death, especially when drug diversion prevention programs aren’t implemented across the whole system. Most health systems have very complex supply chains for controlled substances , expensive oncology drugs…even drugs in the headlines, such as COVID-19 therapies. All are vulnerable to theft at most of the links in the healthcare supply chain, not just patient care. The U.S. Government Accountability Office recognized this threat in its January, 2020 report to the congressional committees.” Although prescription drugs are intended for legitimate medical uses, the prescription drug supply chain may present opportunities for drugs to be averted and abused.” To expose these threats to healthcare executives, Invistics developed a whitepaper that details the issues, offers recommendations for fixing the Leaky Supply Chain and buil...